Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Schroeder

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
BMC Cancer|August 10, 2019
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive womenIlnaz Sepahi, Ulrike Faust, Marc Sturm, et al.
European Journal of Human Genetics : EJHG|July 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patientsChristopher Schroeder, Ulrike Faust, Luisa Krauße, et al.
The Lancet. Oncology|May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trialSherko Kuemmel, Monika Graeser, Peter Schmid, et al.
Ebiomedicine|September 16, 2023
UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescentsAlexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, et al.
Journal of Hepatology|July 12, 2016
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patientMarkus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Journal of Hepatology|November 20, 2016
Erratum to "Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient"Markus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Journal of Medical Genetics|June 29, 2022
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working GroupLéa Guerrini-Rousseau, Julien Masliah-Planchon, Sebastian M Waszak, et al.
Nature Communications|March 14, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursEllen Brenner, Barbara F Schörg, Fatima Ahmetlić, et al.
Journal of Medical Genetics|March 26, 2018
Maternal variants in <i>NLRP</i> and other maternal effect proteins are associated with multilocus imprinting disturbance in offspringMatthias Begemann, Faisal I Rezwan, Jasmin Beygo, et al.
Breast Cancer Research : BCR|January 26, 2018
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancerNana Weber-Lassalle, Jan Hauke, Juliane Ramser, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
BMC Cancer|August 10, 2019
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive womenIlnaz Sepahi, Ulrike Faust, Marc Sturm, et al.
European Journal of Human Genetics : EJHG|July 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patientsChristopher Schroeder, Ulrike Faust, Luisa Krauße, et al.
The Lancet. Oncology|May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trialSherko Kuemmel, Monika Graeser, Peter Schmid, et al.
Ebiomedicine|September 16, 2023
UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescentsAlexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, et al.
Journal of Hepatology|July 12, 2016
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patientMarkus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Journal of Hepatology|November 20, 2016
Erratum to "Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient"Markus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Journal of Medical Genetics|June 29, 2022
Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working GroupLéa Guerrini-Rousseau, Julien Masliah-Planchon, Sebastian M Waszak, et al.
Nature Communications|March 14, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursEllen Brenner, Barbara F Schörg, Fatima Ahmetlić, et al.
Journal of Medical Genetics|March 26, 2018
Maternal variants in <i>NLRP</i> and other maternal effect proteins are associated with multilocus imprinting disturbance in offspringMatthias Begemann, Faisal I Rezwan, Jasmin Beygo, et al.
Breast Cancer Research : BCR|January 26, 2018
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancerNana Weber-Lassalle, Jan Hauke, Juliane Ramser, et al.
Pageof 8